ID REV1_MOUSE Reviewed; 1249 AA. AC Q920Q2; Q9QXV2; DT 15-FEB-2005, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 27-MAR-2024, entry version 160. DE RecName: Full=DNA repair protein REV1; DE EC=2.7.7.-; DE AltName: Full=Rev1-like terminal deoxycytidyl transferase; GN Name=Rev1; Synonyms=Rev1l; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND TISSUE SPECIFICITY. RC STRAIN=C3H/He; TISSUE=Liver; RX PubMed=11711549; DOI=10.1074/jbc.m110149200; RA Masuda Y., Takahashi M., Fukuda S., Sumii M., Kamiya K.; RT "Mechanisms of dCMP transferase reactions catalyzed by mouse Rev1 RT protein."; RL J. Biol. Chem. 277:3040-3046(2002). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Poltoratsky V.P., Scharff M.D.; RT "Mus musculus REV1 protein (Rev1) mRNA, complete cds."; RL Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP INTERACTION WITH MAD2L2; POLH; POLI AND POLK. RX PubMed=14657033; DOI=10.1093/emboj/cdg626; RA Guo C., Fischhaber P.L., Luk-Paszyc M.J., Masuda Y., Zhou J., Kamiya K., RA Kisker C., Friedberg E.C.; RT "Mouse Rev1 protein interacts with multiple DNA polymerases involved in RT translesion DNA synthesis."; RL EMBO J. 22:6621-6630(2003). CC -!- FUNCTION: Deoxycytidyl transferase involved in DNA repair. Transfers a CC dCMP residue from dCTP to the 3'-end of a DNA primer in a template- CC dependent reaction. May assist in the first step in the bypass of CC abasic lesions by the insertion of a nucleotide opposite the lesion. CC Required for normal induction of mutations by physical and chemical CC agents. {ECO:0000269|PubMed:11711549}. CC -!- SUBUNIT: Interacts with FAAP20 (By similarity). Monomer. Interacts with CC the DNA polymerase zeta which is composed of REV3L and MAD2L2; the CC interaction with MAD2L2 is direct and requires that REV3L is in its CC closed conformation. Interacts with POLH, POLI and POLK. {ECO:0000250, CC ECO:0000269|PubMed:11711549, ECO:0000269|PubMed:14657033}. CC -!- INTERACTION: CC Q920Q2; Q6NZ36-1: FAAP20; Xeno; NbExp=7; IntAct=EBI-2114764, EBI-15965017; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. CC -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11711549}. CC -!- DOMAIN: The C-terminal domain is necessary for protein interactions. CC -!- SIMILARITY: Belongs to the DNA polymerase type-Y family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB057418; BAB64933.1; -; mRNA. DR EMBL; AF179302; AAF23323.1; -; mRNA. DR EMBL; BC058093; AAH58093.1; -; mRNA. DR CCDS; CCDS14899.1; -. DR RefSeq; NP_062516.2; NM_019570.3. DR RefSeq; XP_006496216.1; XM_006496153.3. DR RefSeq; XP_006496221.1; XM_006496158.2. DR PDB; 2LSG; NMR; -; A=1150-1249. DR PDB; 2LSJ; NMR; -; A=1135-1249. DR PDB; 4FJO; X-ray; 2.72 A; A=1153-1249. DR PDB; 6C59; X-ray; 2.03 A; A=1150-1249. DR PDB; 6C8C; X-ray; 1.50 A; A/B=1150-1249. DR PDBsum; 2LSG; -. DR PDBsum; 2LSJ; -. DR PDBsum; 4FJO; -. DR PDBsum; 6C59; -. DR PDBsum; 6C8C; -. DR AlphaFoldDB; Q920Q2; -. DR BMRB; Q920Q2; -. DR SMR; Q920Q2; -. DR BioGRID; 207845; 15. DR DIP; DIP-41772N; -. DR IntAct; Q920Q2; 5. DR STRING; 10090.ENSMUSP00000027251; -. DR iPTMnet; Q920Q2; -. DR PhosphoSitePlus; Q920Q2; -. DR EPD; Q920Q2; -. DR PaxDb; 10090-ENSMUSP00000027251; -. DR PeptideAtlas; Q920Q2; -. DR ProteomicsDB; 253224; -. DR Antibodypedia; 32824; 185 antibodies from 29 providers. DR DNASU; 56210; -. DR Ensembl; ENSMUST00000027251.12; ENSMUSP00000027251.7; ENSMUSG00000026082.12. DR GeneID; 56210; -. DR KEGG; mmu:56210; -. DR UCSC; uc007asp.1; mouse. DR AGR; MGI:1929074; -. DR CTD; 51455; -. DR MGI; MGI:1929074; Rev1. DR VEuPathDB; HostDB:ENSMUSG00000026082; -. DR eggNOG; KOG2093; Eukaryota. DR GeneTree; ENSGT00940000156374; -. DR HOGENOM; CLU_003901_0_1_1; -. DR InParanoid; Q920Q2; -. DR OMA; IKNGMWM; -. DR OrthoDB; 169741at2759; -. DR PhylomeDB; Q920Q2; -. DR TreeFam; TF314488; -. DR Reactome; R-MMU-110312; Translesion synthesis by REV1. DR Reactome; R-MMU-5655862; Translesion synthesis by POLK. DR Reactome; R-MMU-5656121; Translesion synthesis by POLI. DR Reactome; R-MMU-5656169; Termination of translesion DNA synthesis. DR BioGRID-ORCS; 56210; 4 hits in 114 CRISPR screens. DR ChiTaRS; Rev1; mouse. DR PRO; PR:Q920Q2; -. DR Proteomes; UP000000589; Chromosome 1. DR RNAct; Q920Q2; Protein. DR Bgee; ENSMUSG00000026082; Expressed in dorsal pancreas and 256 other cell types or tissues. DR ExpressionAtlas; Q920Q2; baseline and differential. DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. DR GO; GO:0003684; F:damaged DNA binding; IEA:InterPro. DR GO; GO:0017125; F:deoxycytidyl transferase activity; IDA:MGI. DR GO; GO:0003887; F:DNA-directed DNA polymerase activity; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0070987; P:error-free translesion synthesis; IBA:GO_Central. DR GO; GO:0042276; P:error-prone translesion synthesis; IDA:MGI. DR GO; GO:0009411; P:response to UV; ISO:MGI. DR CDD; cd17719; BRCT_Rev1; 1. DR CDD; cd01701; PolY_Rev1; 1. DR CDD; cd12145; Rev1_C; 1. DR CDD; cd19318; Rev1_UBM2; 2. DR DisProt; DP02625; -. DR Gene3D; 3.30.70.270; -; 2. DR Gene3D; 3.40.1170.60; -; 1. DR Gene3D; 6.10.250.1490; -; 1. DR Gene3D; 6.10.250.1630; -; 1. DR Gene3D; 1.10.150.20; 5' to 3' exonuclease, C-terminal subdomain; 1. DR Gene3D; 3.40.50.10190; BRCT domain; 1. DR Gene3D; 3.30.1490.100; DNA polymerase, Y-family, little finger domain; 1. DR Gene3D; 1.20.58.1280; DNA repair protein Rev1, C-terminal domain; 1. DR InterPro; IPR001357; BRCT_dom. DR InterPro; IPR036420; BRCT_dom_sf. DR InterPro; IPR043502; DNA/RNA_pol_sf. DR InterPro; IPR036775; DNA_pol_Y-fam_lit_finger_sf. DR InterPro; IPR017961; DNA_pol_Y-fam_little_finger. DR InterPro; IPR025527; HUWE1/Rev1_UBM. DR InterPro; IPR012112; REV1. DR InterPro; IPR031991; Rev1_C. DR InterPro; IPR038401; Rev1_C_sf. DR InterPro; IPR047346; Rev1_UBM1/2. DR InterPro; IPR043128; Rev_trsase/Diguanyl_cyclase. DR InterPro; IPR001126; UmuC. DR PANTHER; PTHR45990; DNA REPAIR PROTEIN REV1; 1. DR PANTHER; PTHR45990:SF1; DNA REPAIR PROTEIN REV1; 1. DR Pfam; PF00533; BRCT; 1. DR Pfam; PF00817; IMS; 2. DR Pfam; PF11799; IMS_C; 1. DR Pfam; PF21704; POLH-Rev1_HhH; 1. DR Pfam; PF16727; REV1_C; 1. DR Pfam; PF14377; UBM; 2. DR PIRSF; PIRSF036573; REV1; 1. DR SMART; SM00292; BRCT; 1. DR SUPFAM; SSF52113; BRCT domain; 1. DR SUPFAM; SSF56672; DNA/RNA polymerases; 1. DR SUPFAM; SSF100879; Lesion bypass DNA polymerase (Y-family), little finger domain; 1. DR PROSITE; PS50172; BRCT; 1. DR PROSITE; PS50173; UMUC; 1. DR Genevisible; Q920Q2; MM. PE 1: Evidence at protein level; KW 3D-structure; DNA damage; DNA repair; DNA synthesis; DNA-binding; KW Magnesium; Metal-binding; Nucleotidyltransferase; Nucleus; KW Reference proteome; Transferase. FT CHAIN 1..1249 FT /note="DNA repair protein REV1" FT /id="PRO_0000173993" FT DOMAIN 44..131 FT /note="BRCT" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00033" FT DOMAIN 417..651 FT /note="UmuC" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00216" FT REGION 253..323 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 350..360 FT /note="Interaction with target DNA" FT /evidence="ECO:0000250" FT REGION 651..654 FT /note="Interaction with target DNA" FT /evidence="ECO:0000250" FT REGION 707..715 FT /note="Interaction with target DNA" FT /evidence="ECO:0000250" FT REGION 1035..1109 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1150..1249 FT /note="Protein interaction domain; mediates interaction FT with DNA polymerase zeta" FT MOTIF 1072..1078 FT /note="Nuclear localization signal" FT /evidence="ECO:0000255" FT COMPBIAS 256..272 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 273..323 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1045..1060 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 355 FT /ligand="dCTP" FT /ligand_id="ChEBI:CHEBI:61481" FT /evidence="ECO:0000250" FT BINDING 421..425 FT /ligand="dCTP" FT /ligand_id="ChEBI:CHEBI:61481" FT /evidence="ECO:0000250" FT BINDING 421 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00216" FT BINDING 421 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00216" FT BINDING 508..514 FT /ligand="dCTP" FT /ligand_id="ChEBI:CHEBI:61481" FT /evidence="ECO:0000250" FT BINDING 520 FT /ligand="dCTP" FT /ligand_id="ChEBI:CHEBI:61481" FT /evidence="ECO:0000250" FT BINDING 568 FT /ligand="dCTP" FT /ligand_id="ChEBI:CHEBI:61481" FT /evidence="ECO:0000250" FT BINDING 568 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00216" FT BINDING 569 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00216" FT SITE 768 FT /note="Interaction with target DNA" FT /evidence="ECO:0000250" FT SITE 781 FT /note="Interaction with target DNA" FT /evidence="ECO:0000250" FT CONFLICT 438 FT /note="K -> T (in Ref. 2; AAF23323)" FT /evidence="ECO:0000305" FT CONFLICT 555 FT /note="L -> W (in Ref. 2; AAF23323)" FT /evidence="ECO:0000305" FT CONFLICT 638 FT /note="F -> S (in Ref. 2; AAF23323)" FT /evidence="ECO:0000305" FT CONFLICT 661 FT /note="L -> S (in Ref. 2; AAF23323)" FT /evidence="ECO:0000305" FT CONFLICT 684 FT /note="K -> R (in Ref. 2; AAF23323)" FT /evidence="ECO:0000305" FT HELIX 1163..1176 FT /evidence="ECO:0007829|PDB:6C8C" FT HELIX 1182..1197 FT /evidence="ECO:0007829|PDB:6C8C" FT HELIX 1201..1216 FT /evidence="ECO:0007829|PDB:6C8C" FT HELIX 1221..1241 FT /evidence="ECO:0007829|PDB:6C8C" FT TURN 1242..1245 FT /evidence="ECO:0007829|PDB:6C8C" FT STRAND 1246..1248 FT /evidence="ECO:0007829|PDB:6C8C" SQ SEQUENCE 1249 AA; 137341 MW; F82E0B6171AA3F75 CRC64; MRRGGWRKRT ENDGWEKWGG YMAAKVQKLE EQFRTDAANQ KDGTASAIFS GVAIYVNGYT DPSAEELRNL MMLHGGQYHV YYSRSKTTHI IATNLPNAKI KELKGEKVIR PEWIVESIKA GRLLSSAPYQ LYTKPSAAQK SLNFNPVCKP EDPGPGPSNR AKQLNNRVNH IIKKIETESE VKANGLSSWN EDGVNDDFSF EDLEHTFPGR KQNGVMHPRD TAVIFNGHTH SSNGALKTQD CLVPVGNSVA SRLSLDSTQE EKRAEKSNAD FRDCTVQHLQ HSTRSADALR SPHRTNSLSP SLHSNTKING AHHSTVQGPS STKSTSVLTL SKVAPSVPSK PSDCNFISDF YSRSRLHHIS TWKCELTEFV NTLQRQSSGI FPGREKLKKV KTGRSSLVVT DTGTMSVLSS PRHQSCVMHV DMDCFFVSVG IRNRPDLKGK PVAVTSNRGT GTAPLRPGAN PQLEWQYYQN RALRGKAADI PDSSVWENQD STQTNGIDSV LSKAEIASCS YEARQVGIKN GMFFGYAKQL CPNLQAVPYD FHACREVAQA MYETLASYTH SIEAVSCDEA LIDVTDILAE TKLSPEEFAA ALRIEIKDKT KCAASVGIGS NILLARMATK KAKPDGQYHL QPDEVDDFIR GQLVTNLPGV GRSMESKLAS LGIKTCGDLQ CLTMAKLQKE FGPKTGQMLY RFCRGLDDRP VRTEKERKSV SAEINYGIRF TQPKEAEAFL LSLSEEIQRR LEAAGMKGKR LTLKIMVRKP GAPIETAKFG GHGICDNIAR TVTLDQATDS AKIIGKATLN MFHTMKLNIS DMRGVGIQVN QLVPANSNLS TCSSRPSAQS SLFSGRPHSV RDLFQLQKAK KPTEEEHKEV FLAAVDLEVS STSRACGLLS PLSAHLAASV SPDTNSGECS RKWNGLHSPV SGQSRLNLSI EVPSPSQIDQ SVLEALPLDL REQIEQVCAA QQGEPRGKKK EPVNGCSSGV LPHPVGTVLL QIPEPQEPCN SDSKISVIAL PAFSQVDPDV FAALPAELQK ELKAAYDQRQ RQGEDTTHQQ PTSTSVPKNP LLQLKPPAMK DKRNKRKNLI GSPRKSPLKN KLLSSPAKTL PGAYGSPQKL MDGFLQHEGM ASERPLEEVS ASTPGAQDLS SLLPGQSSCF RPAAPNLAGA VEFSDVKTLL KEWITTISDP MEEDILQVVR YCTDLIEEKD LEKLDLVIKY MKRLMQQSVE SVWNMAFDFI LDNVQVVLQQ TYGSTLKVT //